Recruiting trial = ; Ongoing trial = ; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

UNITED KINGDOM

Greater London
LONDON

An open label, multi-centre, Phase I/II dose escalation trial of a recombinant adeno-associated virus vector (AAV2/8-hCARp.hCNGB3) for gene therapy of adults and children with achromatopsia owing to defects in CNGB3 - Gene Therapy for Achromatopsia: CNGB3

MeiraGTx UK II Limited

More details

UNITED KINGDOM

Greater London
LONDON

Long-term Follow-up Study of Participants Following an Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector for Gene Therapy of Adults and Children With Achromatopsia Owing to Defects in CNGB3

University College London - UCL Darwin Building

University College London

More details